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Hypotrichosis simplex (HS) is a group of isolated alopecias that can be inherited as an autosomal-dominant or
an autosomal-recessive trait. Hair loss usually begins in early childhood, and is diffuse and progressive.
Mutations in LIPH, which encodes lipase member H, have recently been shown to cause an autosomal-recessive
form of HS. Here we describe an Austrian HS patient who was found to be carrying compound heterozygous
mutations in the LIPH gene: a 7-bp frameshift duplication (c.403_409dup; p.Gln137HisfsX1) and a recently
reported 30-amino acid in-frame duplication (c.280_369dup; p.Gly94_Lys123dup). To examine the impact of LIPH
mutations on lipid metabolism, we established an in vitro assay to measure the action of this phospholipase in a
cell-based system. Both the 7-bp duplication frameshift mutation and all known in-frame mutations were
observed to reduce the in vitro activity of the lipase in response to the addition of phosphatidic acid, the
substrate of lipase H. The reduced production of lysophosphatidic acid (LPA) led to a reduced response of cells
expressing the human G-protein-coupled receptor p2y5 (p2y5) receptor. Our study increases the spectrum of
known LIPH mutations and provides biochemical evidence for the important role of lipase H and its product
LPA in human hair growth.
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INTRODUCTION
Hypotrichosis simplex (HS, MIM 146520, MIM 605389 and
MIM 611452) is a rare form of isolated hypotrichosis, which
can be inherited in either an autosomal-dominant or
autosomal-recessive mode. Hair loss usually starts in early
childhood and progresses until adulthood. The extent of hair
loss on the scalp and body is variable and ranges from slight
hair loss to complete baldness. HS affects men and women
equally. Mutations in a small number of genes are known
to cause HS: CDSN (encoding corneodesmosin; Levy-
Nissenbaum et al., 2003), DSG4 (encoding desmoglein 4;
Kljuic et al., 2003), LIPH (encoding lipase, member H, LIPH;
Kazantseva et al., 2006), and P2RY5 (encoding a G-protein-
coupled receptor; Pasternack et al., 2008).
In 2006, the LIPH gene was identified by Kazantseva et al.
as being responsible for autosomal-recessive HS in 50
families from the Volga-Ural region of Russia. These patients
typically present with retarded or arrested hair growth, which
results in a short hair length. Histo-pathological studies show
abnormal morphology of hair follicles and dystrophic and
fragile hair. All of the Russian patients carry a deletion that
encompasses the whole of exon 4 of the LIPH gene. To date,
two further deletion mutations have been identified in exon 2
(c.346_350del; Ali et al., 2007) and in exon 4 (c.659_660del;
Jelani et al., 2008) in consanguineous Pakistani families.
An in-frame duplication mutation of 30 amino acids in
exon 2 (c.280_369dup) has been recently reported in
consanguineous and distantly related Israeli families of Arab
Moslem descent and in one family of Turkish origin (Nahum
et al., 2008; Figure 1a).
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The G-protein-coupled receptor, p2y5, was initially named P2Y5, which
applies to G-protein-coupled receptors for extracellular nucleotides. As the
protein has been shown to play a role as a receptor for LPA, but not for
nucleotides (Li et al., 1997; Pasternack et al., 2008), we have changed the
designation to p2y5 according to nomenclature of the International Union of
Basic and Clinical Pharmacology.
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In this report, we describe a Central European patient with
HS who was found to harbor compound heterozygous
mutations in the LIPH gene. To our knowledge, LIPH
mutations have not been previously reported for Central
Europeans. The 9-year-old female patient is the only child
of healthy, non-consanguineous parents originating from
Western Austria. At birth, the girl had thick, curly hair, which
she had lost by the age of 6 months. Since then she has had
only sparse, light-colored, short, and fragile hair. No other
abnormalities have been observed. We therefore hypothe-
sized that the girl might carry mutations in the LIPH gene.
Despite an increasing number of known mutations, no
biochemical or pharmacological tool has existed to assess the
consequence of LIPH mutations on lipid metabolism and hair
growth. We recently suggested that LIPH, its product,
lysophosphatidic acid (LPA), or a closely related analog,
formed from phosphatidic acid (PA), and the newly identified
G-protein-coupled receptor for LPA, p2y5, act in the same
pathway to control hair growth in humans (Pasternack et al.,
2008). On the basis of this finding, we designed a bioassay to
measure LPA production by LIPH through cells that express
the recombinant p2y5 receptor. This study applies this
approach to show the effects of LIPH mutations on lipid
metabolism and LPA signaling.
RESULTS
By sequencing the complete coding region of the LIPH
gene in the affected girl, we identified a 7-bp duplication
(c.403_409dup; p.Gln137HisfsX1) and a duplication muta-
tion of 30 amino acids (c.280_369dup; p.Gly94_Lys123dup),
both of which are located in exon 2 in a heterozygous state.
The first mutation leads to a frameshift and a premature stop
codon that results in a truncated protein, whereas the last
mutation is in-frame and has already been reported as being a
causative mutation (Nahum et al., 2008). The mother of the
patient carries the heterozygous c.280_369dup mutation, but
a DNA sample from the father was not available for analysis.
When screening a consanguineous Turkish family of
Aramaic-Christian origin with three HS-affected siblings, we
were able to identify the c.280_369dup mutation in a
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Figure 1. Compilation of all reported LIPH mutations and genomic structure of the LIPH gene. (a) Schematic diagram of the human Lipase H (LIPH) gene
including exon–intron structure. Exons are numbered and depicted as solid bars. Up-to-date identified mutations are given below; the mutations identified in this
study are shown in bold letters. (b) Sequence analysis of cloned LIPH mutations and the respective wild-type sequences. The mutations are carried by the
Austrian HS patient in a compound heterozygous state. (c) Known LIPH mutations, including the respective reference.
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homozygous state in three patients, and in a heterozygous
state in their parents, bringing the total number of families
reported to be carrying this duplication to six. It is of note that
no clinical differences were observed between the Austrian
patient and the Turkish patients. In addition, histological
examination of a skin biopsy from the scalp of the oldest
Turkish sibling (conducted at the age of 14 years) showed a
severe hypotrichosis with hair miniaturization and a follicular
hyperkeratosis. The sebaceous glands were normal. The
lower part of the hair follicle showed fibrosis and some
lymphocytic infiltrates. The hair bulb was located at an
abnormal high dermal level.
To examine the impact of different LIPH mutations on lipid
metabolism, we established an in vitro assay to measure the
action of this phospholipase within a cell-based system. We
analyzed the 7-bp duplication frameshift mutation (Figure 1b)
and all known in-frame mutations (Figure 1c) to prove their
pathogenicity. We expressed LIPH wild-type and mutant
proteins heterologously in Chinese hamster ovary cells (Flp-
In-CHO cells). The bioassay measures the conversion of PA to
LPA as well as the detection of the newly produced LPA by
ascertaining the responses of cells expressing the human
recombinant p2y5 receptor, using a cAMP response element
(CRE)-directed luciferase reporter gene assay. For this purpose,
cells expressing wild-type or mutant LIPH were incubated with
the substrate PA (Figure 2a, left panel). The supernatant of these
cells was then added to the cells expressing the LPA receptor,
p2y5, and luciferase (Figure 2a, middle panel), the latter being
under the control of the CRE monitoring the activation of the
receptor by products present in the supernatant.
After incubation with PA, the supernatant of cells
expressing the wild-type form of LIPH increased the
luciferase activity of cells expressing the recombinant p2y5
receptor byB20% over the background activity (response to
the supernatant without addition of the substrate PA, Figure
2b, columns 3 and 4; Po0.001). When PA was added to the
medium of cells transfected with the empty vector only (that
is, without the sequence encoding for the recombinant LIPH),
no response was observed in the bioassay (Figure 2b,
columns 1 and 2). All mutations, that is, the c.280_369dup
mutation, the complete deletion of exon 4 (c.527_628del),
and the 7-bp duplication mutation (c.403_409dup), resulted
in the loss of lipase activity (Figure 2b, columns 5–10;
Po0.001 compared with response to the supernatant from
cells expressing the wild-type LIPH). There were no
statistically significant differences between the data obtained
with cells expressing the mutants or the empty vector.
To confirm our results, we designed a second assay using
the non-fluorescent phospholipase substrate, PED-A1 (N-((6-
(2,4-DNP)amino) hexanoyl)-1-(BODIPY FL C5)-2-hexyl-
sn-glycero-3-phosphoethanolamine), to assess the activity
of LIPH and mutants transiently expressed in Flp-In-CHO
cells. After the addition of 0.5 mM PED-A1 and monitoring
of fluorescence intensity as a measure of the production
of fluorescent phospholipase products, a highly significant
difference between LIPH wild-type and all three mutants was
observed. This was statistically evaluated for the measure-
ments taken 10minutes after the addition of PED-A1
(Po0.001 compared with values observed from cells expres-
sing wild-type LIPH; data not shown) and those obtained after
30minutes (Figure 2c; Po0.001 compared with values
observed from cells expressing wild-type LIPH). After 2 hours,
the differences were smaller, but still detectable (Po0.05
compared with values observed from cells expressing wild-
type LIPH; data not shown). The whole-protein amounts of
cells expressing the respective LIPH constructs did not differ
(data not shown).
DISCUSSION
To date, three reports have confirmed the causative role of
LIPHmutations in the pathogenesis of HS. This study presents a
patient of Central European origin with compound hetero-
zygous mutations and Turkish siblings with a known homo-
zygous duplication mutation. To our knowledge, compound
heterozygous mutations have not been reported so far for LIPH.
Recently, we identified mutations in the G-protein-
coupled receptor, p2y5, as being another cause of auto-
somal-recessive HS. We were also able to show that LPA (or a
closely related analog) is a ligand of the p2y5 receptor and
that the CRE-directed luciferase reporter gene assay provides
a means of measuring activation of the p2y5 receptor
(Pasternack et al., 2008). On the basis of the fact that
mutations in both the LIPH gene (Kazantseva et al., 2006) and
the P2RY5 gene (Pasternack et al., 2008) cause HS, we
hypothesized that LIPH and the LPA receptor, p2y5, act along
a common physiological pathway that regulates human hair
growth and differentiation. This hypothesis was substantiated
by the results of this study. We have established an assay to
indirectly measure the activity of LIPH. Our data clearly show
that all examined LIPH mutations result in a significantly
reduced activity of the encoded enzyme lipase H.
The 7-bp duplication in exon 2 (c.403_409dup), which
leads to a frameshift and results in a truncated protein, shows
complete abolishment of enzyme activity, comparable with
cells transfected with the empty pcDNA3.1 vector only. This
is in accordance with the absence of three important catalytic
amino-acid residues, namely Ser154, Asp178, and His248, in
the truncated protein (Sonoda et al., 2002).
The complete deletion of exon 4 of the LIPH gene
eliminates just one evolutionarily conserved domain that
harbors the catalytic amino acid Asp178. This mutation also
leads to the complete abolition of enzyme activity. The 30-
amino acid duplication in exon 2 (c.280_369dup) leads to a
loss of enzyme activity, despite the fact that this mutation
does not affect the important amino-acid residues, the lid
domain, nor the surface loop b9, all of which are required for
substrate recognition (Aoki et al., 2007). We assume that the
duplication may alter the tertiary structure of the protein, thus
resulting in attenuated lipase activity. The slight differences in
the results obtained in the bioassay (Figure 2b) and the
fluorometric analysis (Figure 2c) are likely to be due to the
different substrates used in the assays.
Interestingly, we did not observe any differences in the
severity of hair loss in patients carrying different LIPH
mutations. The number of patients included in our study is
limited, however, and it might still be that genotype–pheno-
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type correlations can be identified through the investigation
of larger patient samples.
In conclusion, our study broadens current understanding
of the critical role of lipid metabolism in hair ontogenesis and
provides a previously unreported experimental tool for
assessing the function of this system in a practical and
reproducible in vitro system. It is likely that additional
elements involved in this pathway are associated with the
regulation of hair growth and differentiation, and thus with
hair disorders in humans. Future systematic study of
monogenic hair diseases will be instrumental in the further
delineation of this pathway, as well as in the identification of
novel therapeutic targets in more common, acquired hair
abnormalities.
MATERIALS AND METHODS
Mutation analysis and cloning of LIPH
The study was conducted in adherence to the Declaration of
Helsinki Principles. Ethical approval for the study was obtained from
the Ethics Committee of the University Hospital Bonn. After
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Figure 2. Pharmacological and biochemical analyses of the function of wild-type LIPH and mutant constructs (c.280_369dup, c.527_628del, and
c.403_409dup). (a) Schematic of experimental design of the bioassay used for the experiments shown in panel b. (b) Results of the bioassay monitoring the
conversion of phosphatidic acid (3-sn-phosphatidic acid, PA, 100mM) by LIPH or mutant constructs. The supernatant of Chinese hamster ovary (CHO)
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expressing the recombinant p2y5 receptor. The activation of this receptor was assessed by means of a cAMP-dependent luciferase reporter assay (pCRE-luc).
Results are given as a percentage of the respective solvent control (con). pcDNA3.1, empty vector. Means±SEM of 10 measurements. (c) Lipase activity
monitored by the increase in fluorescence due to the cleavage of the substrate PED-A1 (N-((6-(2,4-DNP)amino) hexanoyl)-1-(BODIPY FL C5)-2-hexyl-sn-
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obtaining written informed consent, blood samples were collected
for DNA extraction in accordance with standard methods. We
amplified using PCR and directly sequenced the complete coding
region of the LIPH gene including exon–intron boundaries. The PCR
products were purified with the GFX PCR DNA Purification Kit
(Amersham Biosciences, Buckinghamshire, UK) and were directly
sequenced using the BigDye Terminator v1.1 Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA) on an ABI 3100 Genetic
Analyzer (Applied Biosystems).
The LIPH mutations described in this study, as well as the
deletion of exon 4 (Kazantseva et al., 2006) and the wild-type
sequence, were cloned into the pcDNA3.1 vector (Invitrogen,
Paisley, UK). Primer sequences are available upon request.
Pharmacological analysis
Reporter gene assay detecting the product of LIPH in the
supernatant of cells. Flp-In-CHO cells of passages 19–23 were
transiently transfected with different LIPH constructs (LIPH wild-type,
p.Gly94_Lys123dup, p.Gln137HisfsX1, and p.Gly176_Asp209del)
using Lipofectamine 2000 (Invitrogen). Using separate flasks, Flp-In-
CHO cells were co-transfected with P2RY5 wild-type sequence and
the pCRE-luc vector (Stratagene, Amsterdam, The Netherlands). For
control experiments, Flp-In-CHO cells transfected with the empty
pcDNA3.1 vector were used. The cells were then cultured in 24-well
plates. Two days after transfection, cells were washed three times
with 37 1C warm Opti-mem (Invitrogen). PA (100mM, 3-sn-phospha-
tidic acid sodium salt; Sigma, Deisenhofen, Germany) or its solvent
(chloroform, Merck, Darmstadt, Germany) was added to cells
expressing LIPH constructs for 30minutes. The medium of cells
transiently expressing the human p2y5 receptor was then removed
and replaced by 500 ml supernatant of the LIPH expressing cells (that
is, the products of the conversion of PA were added to the cells
expressing the receptor). The activation of the p2y5 receptor was
then assessed by the CRE-directed luciferase reporter gene assay after
an incubation period of 3 hours at 36.5 1C, as described previously
(Hoffmann et al., 2008; Pasternack et al., 2008). The medium was
then removed and replaced by 50 ml of buffer and 50ml of Bright-Glo
luciferase assay solution (Promega, Mannheim, Germany). The
activity of luciferase in the supernatant was analyzed at room
temperature using a single-photon luminometer (Berthold, Wildbad,
Germany). Relative light units were normalized against the
respective solvent control for each LIPH construct.
Monitoring of enzyme function by the use of fluorescent lipids
Flp-In-CHO cells of passages 18–23 were transiently transfected with
different LIPH constructs (LIPH wild-type, p.Gly94_Lys123dup,
p.Gln137HisfsX1, and p.Gly176_Asp209del) or with the empty vector
pcDNA3.1 (Invitrogen). Cells were seeded into a 96-well plate (BD
Biosciences, Franklin Lakes, NJ). At 2 days after transfection, the
medium was replaced by HBSS (Hanks’ balanced salt solution)
containing 0.5mM PED-A1 (Invitrogen). PED-A1 is composed of a
quencher group (dinitrophenyl) on the glycerophosphoethanolamine
head group and BODIPY dye-labeled acyl chains at the sn-1 position.
Cleavage of the molecule increases green fluorescence by uncoupling
the quenched state. As a result of this, phospholipase activity was
monitored every 150 seconds for 2 hours at 25 1C by the FLUOstar
Optima Microplate Reader (BMG LABTECH, Offenburg, Germany;
excitation filter 485nm, emission filter 520nm).
Determination of protein amounts
After measurement of lipase activity by PED-A1, the supernatant was
removed and cells were lysed in 50ml of 1 M NaOH (Merck) for
30minutes. The amount of protein in one random sample for each
construct was determined with the DC Protein Assay (Bio-Rad,
Mu¨nchen, Germany) according to the manufacturer’s instructions.
The amount of protein ranged from 15±3mg to 29±9mg protein per
well. Statistical analyses showed no differences in protein amounts
in cells expressing the different lipase constructs.
Statistical analysis of pharmacological data
The values are represented as means±standard errors (SEM).
For statistical comparison, an analysis of variance followed by
Bonferroni’s multiple comparison test was performed using GraphPad
Prism version 4.03 (GraphPad, San Diego, CA). Po0.05 or lower
was the significance criterion.
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